ObjectiveCilostazol is indicated for alleviating intermittent claudication (IC) in stable-phase peripheral arterial disease (PAD) patients. Conducting data mining on adverse events (AEs) of cilostazol in the U.S.
Lufeng Peng +4 more
doaj +1 more source
Drug-induced Fatal Arrhythmias: Acquired long QT and Brugada Syndromes [PDF]
Since the early 1990s, the concept of primary “inherited” arrhythmia syndromes or ion channelopathies has evolved rapidly as a result of revolutionary progresses made in molecular genetics.
Ai, Tomohiko +3 more
core +2 more sources
Authors' reply: Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630–1638) [PDF]
John Stevens +7 more
openalex +1 more source
Background In order to evaluate the impact of cilostazol on endothelial function, we compared the changes of flow-mediated dilation (FMD) between aspirin and cilostazol groups in patients with acute cerebral ischemia.
Seong-Joon Lee +5 more
doaj +1 more source
Effects of Cilostazol on Angiogenesis in Diabetes through Adiponectin/Adiponectin Receptors/Sirtuin1 Signaling Pathway [PDF]
Shih‐Ya Tseng +3 more
openalex +1 more source
Evaluation of antidepressant and anxiolytic activity of phosphodiesterase 3 inhibitor - Cilostazol
Background: Cyclic nucleotide Phosphodiesterases (PDEs) are ubiquitously distributed in mammalian tissues and play a major role in cell signaling by hydrolyzing cyclic Adenosine Monophosphate (cAMP) and cyclic Guanosine Monophosphate (cGMP).
Dipesh S Patel +2 more
doaj +1 more source
Nitric oxide-induced activation of the AMP-activated protein kinase alpha2 subunit attenuates IKappaB kinase activity and inflammatory responses in endothelial cells [PDF]
Background: In endothelial cells, activation of the AMP-activated protein kinase (AMPK) has been linked with anti-inflammatory actions but the events downstream of kinase activation are not well understood.
Beß, Elke +3 more
core
Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2 [PDF]
Shinichiro Uchiyama +17 more
openalex +1 more source

